Advertisement
Screener

Quanterix Corporation (QTRX) Overview

Quanterix Corporation (QTRX) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -1.04; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.37; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.73; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.77; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$2.30$2.98$3.87$5.02$6.52$8.462025-11-062026-11-06$2.30$4.42$8.50$16.34$31.41$60.392021-11-082026-11-06$2.30$4.84$10.19$21.46$45.20$95.172017-12-072026-11-06$2.30$4.84$10.19$21.46$45.20$95.172017-12-072026-11-06$2.30$4.84$10.19$21.46$45.20$95.172017-12-072026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$2.90
Previous close
$3.67
Change
-$0.77
Change (%)
-21.12%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

QTRX
-42.30%
S&P 500
(m)

1 year

QTRX
-30.10%
S&P 500
(m)

3 years

QTRX
-86.48%
S&P 500
(m)

5 years

QTRX
-92.39%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -1.04

-1.12-0.89-0.66-0.42-0.1931 Mar 2025: estimate (m); actual -0.5331 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.7730 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.7330 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.3731 Mar 2026(m)30 Jun 2026: estimate (m); actual -1.0430 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-1.04(m)(m)
1 Jan 202631 Mar 2026(m)-0.37(m)(m)
1 Jul 202530 Sept 2025(m)-0.73(m)(m)
1 Apr 202530 Jun 2025(m)-0.77(m)(m)
1 Jan 202531 Mar 2025(m)-0.53(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -2.51

-2.77-2.22-1.67-1.12-0.5731 Dec 2021: estimate (m); actual -1.5431 Dec 2021(m)31 Dec 2022: estimate (m); actual -2.6931 Dec 2022(m)31 Dec 2023: estimate (m); actual -0.7531 Dec 2023(m)31 Dec 2024: estimate (m); actual -1.0031 Dec 2024(m)31 Dec 2025: estimate (m); actual -2.5131 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-2.51(m)(m)
1 Jan 202431 Dec 2024(m)-1.00(m)(m)
1 Jan 202331 Dec 2023(m)-0.75(m)(m)
1 Jan 202231 Dec 2022(m)-2.69(m)(m)
1 Jan 202131 Dec 2021(m)-1.54(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 32.91M ■ Earnings -48.93M — Profit margin -148.71%

-60.07M-149.7%-21.72M-115.5%16.64M-81.3%54.99M-47.2%30 Sept 2025: revenue 40.23M; earnings -33.52M; profit margin -83.31%30 Sept 202531 Dec 2025: revenue 43.85M*; earnings -23.17M*; profit margin -52.83%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 36.41M; earnings -17.54M; profit margin -48.17%31 Mar 202630 Jun 2026: revenue 32.91M; earnings -48.93M; profit margin -148.71%30 Jun 2026

31 Dec 2025 ■ Revenue 138.90M ■ Earnings -107.20M — Profit margin -77.18%

-136.73M-95.4%-35.01M-71.0%66.71M-46.6%168.43M-22.2%31 Dec 2022: revenue 105.52M; earnings -99.60M; profit margin -94.39%31 Dec 202231 Dec 2023: revenue 122.37M; earnings -28.40M; profit margin -23.21%31 Dec 202331 Dec 2024: revenue 137.42M; earnings -38.50M; profit margin -28.02%31 Dec 202431 Dec 2025: revenue 138.90M; earnings -107.20M; profit margin -77.18%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$2.90(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$2.90High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning QTRX

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-123.16M
Profit margin
-80.28%
Return on assets · 12 month
-35.43%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
151.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
943.56K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
15.05%*
Total return · month
39.02%*
Total return · quarter
-19.16%*
Total return · half year
2.51%*
Total return · year to date
-42.30%*
Total return · 1 year
-30.10%*
Total return · 3 years
-86.48%*
Total return · 5 years
-92.39%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$153.41M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Quanterix Corporation Overview

View more →

(m)

(m)

SEC CIK
1503274
Industry (SIC)
3826 Laboratory Analytical Instruments
Country of operation
United States
Business address
900 MIDDLESEX TURNPIKE, BILLERICA, Massachusetts, 01821, United States
Fiscal year end
1231
Phone
617-301-9400

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15